Nutritional Rehabilitation in Senegalese HIV-infected Children and Adolescents (SNAC'S)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03101852 |
Recruitment Status :
Completed
First Posted : April 5, 2017
Last Update Posted : March 4, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Malnutrition HIV/AIDS | Dietary Supplement: Plumpy Nut Dietary Supplement: Plumpy Sup | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 185 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Effectiveness and Acceptability of Nutritional Rehabilitation Based on Ready-to-use Food in HIV-infected Children and Adolescents in Senegal: The Multicentre SNAC'S Study |
Actual Study Start Date : | April 2015 |
Actual Primary Completion Date : | March 2017 |
Actual Study Completion Date : | September 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Nutritional therapy
Children included in the study with severe acute malnutrition receive Plumpy Nut: WHO recommends a Plumpy Nut® prescription of 75 to 100 kcal/kg/d in children aged 5 to 10 years and 60 to 90 kcal/kg/d above that age. The lowest value was used and maximum energy intake provided by RUF was limited to 2,000 kcal/d i.e. 4 sachets in order to preserve habitual diet and prevent appetite saturation
|
Dietary Supplement: Plumpy Nut
Other Name: ready-to-use therapeutic food |
Experimental: Nutritional supplementation
Children included in the study with moderate acute malnutrition receive Plumpy Sup: 60kcal/kg/day, limited to 4 doses/day.
|
Dietary Supplement: Plumpy Sup
Other Name: ready-to-use supplementary food |
- Successful nutritional rehabilitation [ Time Frame: up to 12 months ]the child reach his/her target weight defined as weight-for-height >= - 2 z-scores in children < 5years; body mass index for age >= -2 z-score in children >= 5 years
- long-term effectiveness [ Time Frame: 3 months ]the child maintains stable weight (or gains weight) 3 months after reaching target weight.
- long-term effectiveness [ Time Frame: 6 months ]the child maintains stable weight (or gains weight) 6 months after reaching target weight.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 6 Months to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- infected with HIV
- presenting with severe or moderate acute malnutrition
- followed-up in one of the 12 study sites
- written consent of the parent/legal guardian
- verbal assent of the child
Exclusion Criteria:
- pregnancy
- physical and/or mental disability incompatible with the study follow-up
- living far from the study site (about more than 50km)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03101852
Principal Investigator: | Karim Diop, MD | Division de Lutte contre le Sida et les IST, Dakar, Senegal | |
Principal Investigator: | Fatou Niasse-Traore, MD | Comité National de Lutte contre le Sida, Dakar, Senegal |
Responsible Party: | Cecile Cames, Principal investigator, Researcher, Institut de Recherche pour le Developpement |
ClinicalTrials.gov Identifier: | NCT03101852 |
Other Study ID Numbers: |
14SANIN203 |
First Posted: | April 5, 2017 Key Record Dates |
Last Update Posted: | March 4, 2020 |
Last Verified: | March 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
severe acute malnutrition moderate acute malnutrition HIV-infection adolescents |
antiretroviral Africa ready-to-use food outpatient care |
Malnutrition Nutrition Disorders |